Effect of cetirizine hydrochloride on the expression of substance P receptor and cytokines production in human epidermal keratinocytes and dermal fibroblasts

Yaoxue Xuebao

Volumn 43, Issue 4, 2008, Pages 383-387

  Liu, Ji Yong ^a   Zhao, Yong Zhe ^a   Peng, Cheng ^a   Li, Feng Qian ^a   Zhu, Quan Gang ^a   Hu, Jin Hong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cetirizine hydrochloride; Cytokines; Fibroblast; HaCaT cell line; Substance P receptor

Indexed keywords

ANTIALLERGIC AGENT; CETIRIZINE; GAMMA INTERFERON; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ARTICLE; CELL LINE; CYTOLOGY; FIBROBLAST; HUMAN; KERATINOCYTE; METABOLISM;

ANTI-ALLERGIC AGENTS; CELL LINE; CETIRIZINE; FIBROBLASTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-8; KERATINOCYTES; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 44649086391     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ansel JC, Kaynard AH, Armstrong CA, et al. Skin-nervous system interactions [J]. J Invest Dermatol, 1996, 106:198-204.
2. Luger TA. Neuromediators - a crucial component of the skin immune system [J]. J Dermatol Sci, 2002, 30:87-93.
3. O'Sullivan RL, Lipper G, Lerner EA , et al. The neuro-immuno-cutaneous- endocrine network: relationship of mind and skin [J]. Arch Dermatol, 1998, 134:1431-1435.
4. Liu JY, Hu JH, Zhu QG, et al. Effect of cetirizine hydrochloride on the expression of substance P in IgEmediated triphasic cutaneous reaction [J]. Acta Pharm Sin, 2005, 40:649-653.
5. Zhu QG, Hu JH, Fan GR, et al. Metabolism of ketoprofen isopropyl ester in HaCaT cells [J]. Chin Pharm J, 2003, 38:22-25.
6. Zhu QG, Hu JH, Fan GR, et al. Metabolism of ketoprofen isopropyl ester in skin cells [J]. Chin Hosp Pharm J, 2002, 22:195-197.
7. Marriott I, Bost KL. Expression of authentic substance P receptors in murine and human dendritic cells [J]. J Neuroimmunol, 2001, 114:131-141.
8. Bockmann S. Substance P ( NK-1 ) receptor expression by human colonic epithelial cell line Caco-2 [J]. Peptides, 2002, 23:1783-1791.
9. Scholzen T, Armstrong CA, Bunnett NW, et al. Neuropeptides in the skin; interaction between the neuroendocrine and the skin immune system [J]. Exp Dermatol, 1998, 7:81-96.
10. Weiss T, Basketter DA, Schroder KR. In vitro skin irritation; facts and future. State of the review of mechanisms and models [J]. Toxicol In Vitro, 2004, 18: 231-243.
11. Liu JY, Hu JH, Zhu QG, et al. Substance P receptor expression in human skin keratinocytes and fibroblasts [J]. Br J Dermatol, 2006, 155:657-662.
12. Li Q, Shen WB, Zou QG. NMR studies on cetirizine hydrochloride [J]. Acta Pharm Sin, 2003, 38:767-770.
13. Lotz K, Vaughall D, Carson D. Effect of neuropeptides on production of inflammatory cytokines by human monocytes [J]. Science, 1988, 241:1218-1220.
14. Frotsche B, Anton K, Worm M. Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors [J]. J Invest Dermatol, 2002, 119:1059-1064.
15. Kupper TS, Groves RW. The interleukin-l axis and cutaneous inflammation [J]. J Invest Dermatol, 1995, 105:62-66.
16. Kemeny L, Kenderessy AS, Olasz E, et al. The interleukin-8 receptor: a potential target for antipsoriatic therapy [J]. Eur J Pharmacol, 1994, 258:269-272.